ConductScience.org, home

Paper27782834

Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.

Iranpour S and 4 others. J Exp Clin Cancer Res, 2016. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens. Papers, record 27782834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27782834

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
PubMed
Journal
J Exp Clin Cancer Res
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2018-12-02
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iranpour SSoodabeh
2Nejati VVahid
3Delirezh NNowruz
4Biparva PPouria
5Shirian SSadegh

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Breast NeoplasmsMajor topic
Dendritic CellsMajor topic
T-LymphocytesMajor topic
Cancer Vaccines
Cells, Cultured
Female
Humans
Immunotherapy
Interferon-gamma
Interleukin-10
Interleukin-12
Interleukin-4
Lactic Acid
Nanoparticles
Particle Size
Polyglycolic Acid
Polylactic Acid-Polyglycolic Acid Copolymer

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115560948Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.Adv Drug Deliv Rev2005https://conductscience.org/library/papers/15560948PubMed
215479436Vaccines that facilitate antigen entry into dendritic cells.Immunol Cell Biol2004https://conductscience.org/library/papers/15479436PubMed
323201055Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.Eur J Pharm Biopharm2013https://conductscience.org/library/papers/23201055PubMed
420085824Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.Nanomedicine2010https://conductscience.org/library/papers/20085824PubMed
515522656Part I: Vaccines for solid tumours.Lancet Oncol2004https://conductscience.org/library/papers/15522656PubMed
610840197Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.Eur J Pharm Biopharm2000https://conductscience.org/library/papers/10840197PubMed
715771591Cell biology of antigen processing in vitro and in vivo.Annu Rev Immunol2005https://conductscience.org/library/papers/15771591PubMed
815093554Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer.Clin Immunol2004https://conductscience.org/library/papers/15093554PubMed
921679733Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.Adv Drug Deliv Rev2011https://conductscience.org/library/papers/21679733PubMed
1019306994Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.Cell Immunol2009https://conductscience.org/library/papers/19306994PubMed
1112559806Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.Vaccine2003https://conductscience.org/library/papers/12559806PubMed
1215340416Cancer immunotherapy: moving beyond current vaccines.Nat Med2004https://conductscience.org/library/papers/15340416PubMed
1319093773Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.Expert Rev Vaccines2009https://conductscience.org/library/papers/19093773PubMed
1414639362
The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Surgery2003https://conductscience.org/library/papers/14639362PubMed
1516225767Breast cancer immunotherapy.Cell Mol Immunol2004https://conductscience.org/library/papers/16225767PubMed
1619186176Nanoparticle-based targeted drug delivery.Exp Mol Pathol2009https://conductscience.org/library/papers/19186176PubMed
1717217312Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells.Mol Pharm2007https://conductscience.org/library/papers/17217312PubMed
1815821885Recent advances in dendritic cell biology.J Clin Immunol2005https://conductscience.org/library/papers/15821885PubMed
1920692374Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.Nanomedicine2011https://conductscience.org/library/papers/20692374PubMed
2026042126Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.Front Immunol2015https://conductscience.org/library/papers/26042126PubMed

See all 27 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
42193291Immunomodulatory Nanomaterials: Design Strategies, Mechanisms, Biomedical Applications, and Future Perspectives.Biomedicines2026https://conductscience.org/library/papers/42193291PubMed
41439959PLGA Nanoencapsulation Enhances Immunogenicity of Heat-Shocked Melanoma Tumor Cell Lysates.Cells2025https://conductscience.org/library/papers/41439959PubMed
41281637Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy.Mater Today Bio2025https://conductscience.org/library/papers/41281637PubMed
41127507Immunomodulatory Mechanisms of Chronic Wound Healing: Translational and Clinical Relevance.MedComm (2020)2025https://conductscience.org/library/papers/41127507PubMed
40568589Silica-calcium phosphate nanoparticles delivering recombinant influenza hemagglutinin DNA can induce long-lasting T cell immune cross-protection in mice.Front Immunol2025https://conductscience.org/library/papers/40568589PubMed
40281721Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties.Bioengineering (Basel)2025https://conductscience.org/library/papers/40281721PubMed
39600709Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment.Front Immunol2024https://conductscience.org/library/papers/39600709PubMed
39051512Dysfunction of dendritic cells in tumor microenvironment and immunotherapy.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39051512PubMed
38427275PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy.Drug Deliv Transl Res2024https://conductscience.org/library/papers/38427275PubMed
37312116Nanomaterials in tumor immunotherapy: new strategies and challenges.Mol Cancer2023https://conductscience.org/library/papers/37312116PubMed
37240369Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design.Int J Mol Sci2023https://conductscience.org/library/papers/37240369PubMed
36980527The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy.Cancers (Basel)2023https://conductscience.org/library/papers/36980527PubMed
35424648Utilization of metal or non-metal-based functional materials as efficient composites in cancer therapies.RSC Adv2022https://conductscience.org/library/papers/35424648PubMed
34902729Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.Biomaterials2022https://conductscience.org/library/papers/34902729PubMed
33898169Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools.Adv Sci (Weinh)2021https://conductscience.org/library/papers/33898169PubMed
33613696Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine.Ther Adv Med Oncol2021https://conductscience.org/library/papers/33613696PubMed
30871158Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.Int J Mol Sci2019https://conductscience.org/library/papers/30871158PubMed
30607155Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.J Breast Cancer2018https://conductscience.org/library/papers/30607155PubMed
30604321Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin.AAPS J2019https://conductscience.org/library/papers/30604321PubMed
30312721Biomaterials for vaccine-based cancer immunotherapy.J Control Release2018https://conductscience.org/library/papers/30312721PubMed

See all 23 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27782834

GET https://conductscience.org/api/papers/v1/27782834/references?page=2